Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-1-28
pubmed:abstractText
This study explores the ethical issues contained in warning letters (WLs) issued to institutional review boards (IRBs) by the United States Food and Drug Administration (FDA).
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
E
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0147-958X
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
316-23
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
pubmed:affiliation
Research Subject Advocacy Program, General Clinical Research Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. bioethics@go.com
pubmed:publicationType
Journal Article